Not applicableApproved For MarketingNCT01464762
What this trial is testing
Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA